SC 13D

Company

AGIOS PHARMACEUTICALS, INC.

Filed

August 6, 2013

Accession Number

0001193125-13-321700

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →